Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac)_ interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Auteur/autrice de la publication :Admin Post published:27 septembre 2021 Post category:COVID 19 Post comments:0 commentaire Efficacy-and-safety-of-an-inactivated-whole-virion-SARS-CoV-2-vaccine-CoronaVac_-interim-results-of-a-double-blind-randomised-placebo-controlled-phase-3-trial-in-Turkey-2Télécharger Vous devriez également aimer Tests antigeniques rapides 7 mars 2021 Interstitial lung disease and surfactant dysfunction as a secondary manifestation of disease_ insights from lysosomal storage disorders 13 février 2021 Factors Associated With SevereSARS-CoV-2 Infection 11 mars 2021 Laisser un commentaire Annuler la réponseCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Enregistrer mon nom, mon e-mail et mon site dans le navigateur pour mon prochain commentaire.
Interstitial lung disease and surfactant dysfunction as a secondary manifestation of disease_ insights from lysosomal storage disorders 13 février 2021
